Diagnostics Scientific Liaison At AstraZeneca
Do you have expertise in, and passion for, Diagnostics? Would you like to apply your expertise to impact the lives of patients in a company that follows the science and turns ideas into life changing medicines? Then AstraZeneca might be the one for you!
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, having more than 20 brands for the treatment of diseases in different therapeutic areas like Respiratory, Gastroenterology, Cardiovascular, Diabetes and Oncology.
In AstraZeneca we believe in the potential of our people and we'll develop you beyond what you thought is possible. We make the most of your skills and passion by supporting you to see what you can achieve no matter where you start with us.
As Diagnostics Scientific Liaison, you will play a vital role in improving patient's lives. The Diagnostics Scientific Liaison is responsible to be interlocutor in molecular diagnosis in the territory, providing the HCP on the molecular diagnosis / precision medicine in oncology with the final objective of ensuring optimum quality patient identification who can benefit from the targeted therapies offered by AstraZeneca.
What you’ll do
Scientific Information Management and Building Opinion Leader Relationships
Possess solid scientific and diagnostic area knowledge in Oncology and the drive to continually build individual knowledge over time.
Demonstrate deep understanding of the science behind diagnostics including deep understanding of range of diagnostic techniques / platforms and applications to patient identification.
Regular meeting with Opinion Leaders and Influence groups to build partnership, share data, request support, and provide technical support through publications, slide sets, round tables technical discussion.
Respond to requests for information about diagnostic / biomarkers testing unapproved in local markets, presenting objective information, well balanced, substantiated manner that is scientific in tone and content, free of promotional messages, truthful, and is not misleading.
Respond to requests by HCPs for information about technical details of biomarker (methodology, testing process, results interpretation).
Identify, map out and partner with national, regional Opinion Leaders and influence or advocacy groups for biomarkers testing inclusion / adoption.
Work with Pathology, Pulmonology, Genetic and Molecular biology association as partners in scientific activities that help advance biomarker understanding and are consistent with AZ strategy & objectives, such as identifying potential speakers and early adopters of biomarkers for patient´s management and Providing recommendations for advisory board participants.
Support testing access by improving the testing environment
Contribute to testing platforms / techniques implementation in strategic markets to ensure access to biomarkers testing.
Facilitate continuous medical education events for HCPs, through activities that contribute to improve the diagnostic environment (access to testing and its inclusion the routine of patient’s management).
Truly understand the market-specific diagnostic / testing environment, including the science, process, potential barriers, and necessary commercial touch points to propose a treatment-linked diagnostic solution.
Has detailed knowledge of the interconnected Oncology ecosystem of patients, advocacy groups, KOLs, payers & HCPs and knows which decision makers influence the testing protocol.
Participate in the educational material development about testing and ensure the main messages implementation in target audience (HCPs).
Contribute to external stakeholders’ engagement about AZ testing program as value proposition that ensure accurate targeted therapies.
Define samples journey and support patient journey definition in each strategic account, establishing main patient leakage and proposing solutions to close the gaps.
Contribution to Brand and Diagnostic Strategy by supporting cross-functional team(s)
Provide AZ with an understanding of the local diagnostic environment and trends and competitor diagnostic initiatives.
Develop educational activities providing scientific reference about relevance of biomarkers in the patient management to prepare the market in new therapeutic areas or indications.
Communicate HCPs findings, needs, barriers or opportunities with cross-functional team.
Implement local diagnostic activities defined in account plans and speak up when identify a gap or is necessary to redirect local plans.
Facilitate Local Clinical Research (as appropriate)
Participate in development and conduction of local/regional studies with focus on biomarkers testing.
Upon request, assist with various aspects of local clinical trials, including scientific support, site selection and operational issues or feasibility assessments.
Lead local evidence generation about diagnostic (pre-analytical, analytical, and post analytical), biomarker prevalence.
Ensure compliance with the Global Policy on SHE, its supporting documents and the laws and regulations of the local market.
Essential for the role
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be.
Scientific Diagnosis and Ability to transfer Scientific knowledge effectively
Effective Communication& Persuasion
Passion for Customers
Cross Functional Collaboration
Applicants should possess the following essential qualifications to go through initial screening:
University degree from Medical / Science Departments is a must
At least 2 years’ experience in Diagnostic Market and Clinical Testing Market; preferably Oncology experience
Spoken& written English proficiency is a must
Open to frequent travel and must have a valid driving license